STAT

JANUARY 9, 2024

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing. Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates.

349

349

PharmaVoice

JANUARY 9, 2024

Industry leaders predict what it will take for pharma to defeat its financial foes in 2024.

147

147

STAT

JANUARY 9, 2024

On a sweltering day in August 2021, as the engines of a hulking C-17 cargo plane drowned out pops of gunfire and Taliban rocket explosions around them, the young Afghan couple looked down at their 4-month-old son, Mohammad, and felt a shuddering wave of relief. But as the plane lifted above the dusty peaks that hug Kabul like a fortress of sandstone and schist, that feeling grew heavy with grief — for the parents and siblings they were leaving behind, and for Afghanistan, the only home th

341

341

BioPharma Dive

JANUARY 9, 2024

Albert Bourla acknowledged Pfizer’s difficult 2023, while a biotech CEO spoke with BioPharma Dive about building neuroscience startups.

128

128

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

JANUARY 9, 2024

SAN FRANCISCO — The small hotel meeting room was packed like a rush hour subway. Bankers in dark suits were crammed tightly into a small room on the third floor of the Westin St. Francis, lining the aisles and doorways, and spilling out into the hallways where it was impossible to hear. The occasion: Nvidia, the chipmaker whose market capitalization has soared beyond $1 trillion because of its role in the revolutionary work occurring in artificial intelligence, was presenting at the J.P.

317

317

pharmaphorum

JANUARY 9, 2024

Discover how the UK Biobank is leveraging technology and the power of genomics in data-driven disease research. Join the digital revolution in understanding and combating diseases using cutting-edge techniques and large-scale genomic data analysis.

125

125

The Pharmacist

JANUARY 9, 2024

General practices and primary care networks (PCNs) will be able to employ pharmacist trainees from 2025, making them eligible for the recently updated NHS England (NHSE) pharmacist training grant. While some general practice and PCN sites have already hosted pharmacist trainees for part of their placement, this has been administered under a memorandum of understanding […] The post Breaking: GP practices and PCNs now eligible for pharmacist training funding appeared first on The Pharmacist.

124

124

STAT

JANUARY 9, 2024

SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies, seems very comfortable with granting some form of full approval to Elevidys, the Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy, based on his comments to me on Monday night during our “fireside chat” at a STAT event.

288

288

European Pharmaceutical Review

JANUARY 9, 2024

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. This article highlights the manifold applications of AI, particularly cutting-edge image recognition and computer vision systems, which profoundly impact quality control.

Pharmaceutical Manufacturing 122

Pharmaceutical Manufacturing Drug Development 122

STAT

JANUARY 9, 2024

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain. Perhaps the most important thing he’s telling investors at the J.P.

255

255

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

JANUARY 9, 2024

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Aman Wasan, CEO of ArisGlobal, about the digitisation of drug research and development, including using automation to analyse large datasets to identify new drug development opportunities, with patient safety ever at the forefront of such innovations.

Drug Development 119

Drug Development 119

STAT

JANUARY 9, 2024

SAN FRANCISCO  — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so.  Today, Morgan Health’s CEO, Dan Mendelson, aided by a newly hired flack, emailed reporters attending that bank’s annual investor confab, the J.P.

227

227

The Pharmacist

JANUARY 9, 2024

The University of Leicester has introduced a new Master of Pharmacy (MPharm) degree programme in a bid to tackle the UK’s pharmacist shortage. It has been provisionally accredited by the General Pharmaceutical Council (GPhC), and is open to applications for autumn 2024 entry, subject to final approval. The course will offer small group teaching alongside […] The post New MPharm course to be launched in Leicester appeared first on The Pharmacist.

117

117

STAT

JANUARY 9, 2024

Rise and shine, everyone, another busy day is on the way. We can tell by the number of dispatches being filed from the J.P. Morgan Healthcare Conference, which we are helping folks track ( look here ). As for us, we are currently quaffing another cup of stimulation — our choice today is maple bourbon — and foraging for interesting developments.

Vaccines 175

Vaccines Drug Development 175

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharma Times

JANUARY 9, 2024

The fertilised eggs could cultivate tumours for imaging within seven days

116

116

STAT

JANUARY 9, 2024

In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The Readout. To stay on top of the latest scoops and live reporting from the San Francisco conference,  join our newsletter list. After a one-day respite from JPM tradition, the rain returned this morning, leading to some dampened spirits and at least one canny promotional effort.

Drug Pricing 163

Drug Pricing Drug Development 163

PharmExec

JANUARY 9, 2024

Merck has acquired Harpoon Therapeutics with its clinical stage T-cell engager, whereas Johnson & Johnson acquired Ambrx Biopharma with its expertise in next generation antibody drug conjugates and targeted oncologic therapies.

115

115

Pharma Times

JANUARY 9, 2024

Both aim to advance the use of AI-powered cell analysis for cancer, stem cell and cell therapies

114

114

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

JANUARY 9, 2024

Manufacturing problems have scuppered Astellas’ chances of approval in the US this month for zolbetuximab, currently leading the field among Claudin 18.2-targeted drug candidates for cancer.

111

111

Drug Patent Watch

JANUARY 9, 2024

A recent story by NPR echoes the findings of a collaboration between DrugPatentWatch and Bloomberg, which examined increasing competition between generic drug makers. The NPR article discusses the challenges in… The post NPR on how low Drug Prices can Shortages appeared first on DrugPatentWatch - Make Better Decisions.

Drug Pricing 109

Drug Pricing 109

pharmaphorum

JANUARY 9, 2024

Amazon has launched an initiative with Omada Health at JPM that makes it easier for patients to discover and enrol in digital health benefit programmes

110

110

Pharmaceutical Commerce

JANUARY 9, 2024

Review article explores the latest developments surrounding expression and purification strategies.

Vaccines 105

Vaccines 105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JANUARY 9, 2024

JPM: GSK announces $1.4bn deal to buy asthma biotech Aiolos Phil.

110

110

Outsourcing Pharma

JANUARY 9, 2024

Medable Inc. has announced a new intelligent automation technology applied across its clinical trials platform it hopes will cut standard trial build timelines by at least half.

102

102

pharmaphorum

JANUARY 9, 2024

Novo Nordisk Foundation has put $25m of funding into CARB-X, an initiative that aims to tackle antimicrobial resistance (AMR).

105

105

PharmExec

JANUARY 9, 2024

The Healthcare Businesswomen’s Association will honor the recipient at an event later this year in New York City.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

JANUARY 9, 2024

Day 1 of JPM24 ended with no news on a rumoured takeover of Cytokinetics by Novartis, but Boston Scientific confirmed a $3.7bn bid for medtech specialist Axonics.

105

105

European Pharmaceutical Review

JANUARY 9, 2024

Chiesi Farmaceutici (Chiesi Group) and Oak Hill Bio, a clinical-stage neonatology and rare disease therapeutics company, have agreed to collaborate and develop , manufacture , and commercialise an investigational drug candidate for treating pre-term birth complications. OHB-607 is a human IGF-1 replacement of insulin-like growth factor-1 (IGF-1), a key driver of foetal growth and development, and its binding protein, IGFBP-3 for prevention of bronchopulmonary dysplasia in preterm infants, Chiesi

98

98

pharmaphorum

JANUARY 9, 2024

China is third country to approve Alzheimer’s drug Leqembi Phil.

103

103

European Pharmaceutical Review

JANUARY 9, 2024

Pfizer’s oral poly ADP-ribose polymerase (PARP) inhibitor TALZENNA ® (talazoparib), in combination with XTANDI ® (enzalutamide) has been approved for prostate cancer by the European Commission (EC). TALZENNA the first and only PARP inhibitor licensed in the EU for use with XTANDI for patients with mCRPC, with or without gene mutations” The treatment is indicated for adults with metastatic castration-resistant prostate cancer (mCRPC) in individuals where chemotherapy is not clinically indi

Chemotherapy 98

Chemotherapy 98

pharmaphorum

JANUARY 9, 2024

Discover how AI innovations are revolutionising the engagement between life sciences companies and healthcare professionals. Learn about the latest advancements and their impact on the industry.

103

103